The Benzodiazepine Stigma Persists

Freeman, Scott A.

doi:10.4088/jcp.09l05425

Cited by 3 publications

(1 citation statement)

References 17 publications

(19 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Lucki 1986). It has also been suggested that no dose or serum level of a benzodiazepine has been clearly associated with impairment of driving ability (Freeman 2009) and that limiting benzodiazepine prescription 'across the board' is not warranted for this reason. Nevertheless, impairment of motor coordination is dose dependent, so patients should not drive or operate machines immediately after a dose increase.…”

Section: Psychomotor Impairmentmentioning

confidence: 99%

Benzodiazepines for anxiety disorders: maximising the benefits and minimising the risks

Starčević¹

2012

Adv. psychiatr. treat

View full text Add to dashboard Cite

SummaryBenzodiazepines still play an important role in the management of anxiety disorders but dependence is associated with their therapeutic use. The key to effective and safe long-term use of benzodiazepines is: the careful selection of patients who might benefit from them; administration in clinical situations in which they are more likely to be beneficial; use of lower doses and in conjunction with an antidepressant, if possible; monitoring and managing their side-effects; and minimising the risk of withdrawal symptoms and relapse, mainly through tapering the dose and/or combining with effective psychological interventions.

show abstract

Section: Psychomotor Impairmentmentioning

confidence: 99%

Benzodiazepines for anxiety disorders: maximising the benefits and minimising the risks

Starčević¹

2012

Adv. psychiatr. treat

View full text Add to dashboard Cite

show abstract

The role of alprazolam for the treatment of panic disorder in Australia

Moylan

Giorlando

Nordfjærn³

et al. 2012

Aust N Z J Psychiatry

View full text Add to dashboard Cite

Alprazolam has shown efficacy for control of PD symptoms, particularly in short-term controlled clinical trials, but is no longer recommended as a first-line pharmacological treatment due to concerns about the risks of developing tolerance, dependence and abuse potential. Almost no evidence is available comparing alprazolam to current first-line pharmacological treatment. Despite this, prescription rates are increasing. A number of potential issues including use in overdose and impact on car accidents are noted. conclusion: Although effective for PD symptoms in clinical trials, a number of potential issues may exist with use. Consideration of its future place in PD treatment in Australia may be warranted.

show abstract

The reappraisal of benzodiazepines in the treatment of anxiety and related disorders

Starčević

2014

Expert Review of Neurotherapeutics

View full text Add to dashboard Cite

Benzodiazepines (BDZs) continue to be shrouded in controversy, mainly because of dependence associated with their long-term use and some of their side effects. Despite treatment recommendations favoring newer antidepressants, BDZs are still commonly prescribed for anxiety and related disorders. Recent studies have demonstrated that long-term use of BDZs for these conditions can be effective and safe and that BDZs can be combined with psychological therapy and antidepressants to produce optimal outcomes. Such findings, along with a failure to convincingly demonstrate the overall superiority of alternative pharmacotherapy for anxiety and related disorders, have given an impetus to a reconsideration of the role of BDZs. This article reviews BDZs and other pharmacotherapy options for anxiety and related disorders and suggests that treatment guidelines should acknowledge that BDZs can be used as first-line, long-term pharmacological treatment for panic disorder, generalized anxiety disorder and social anxiety disorder.

show abstract

The Benzodiazepine Stigma Persists

Cited by 3 publications

References 17 publications

Benzodiazepines for anxiety disorders: maximising the benefits and minimising the risks

Benzodiazepines for anxiety disorders: maximising the benefits and minimising the risks

The role of alprazolam for the treatment of panic disorder in Australia

The reappraisal of benzodiazepines in the treatment of anxiety and related disorders

Contact Info

Product

Resources

About